Call for Abstract

9th Asia Pacific STD and Infectious Diseases Congress, will be organized around the theme “Advancements, Novel approaches for prevention & control of STD and Infectious Diseases”

STD Asia Pacific Congress 2019 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in STD Asia Pacific Congress 2019

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Chlamydia
  • Track 1-2Gonorrhea
  • Track 1-3Genital Herpes
  • Track 1-4Syphilis
  • Track 1-5Human Papillomavirus
  • Track 1-6Viral Hepatitis
  • Track 2-1Cytomegalovirus
  • Track 2-2Genital Warts
  • Track 2-3Hepatitis
  • Track 2-4Herpes
  • Track 2-5Respiratory infections
  • Track 2-6Gastrointestinal tract Infections
  • Track 2-7Neural Infection
  • Track 2-8Viral Tumorigenesis
  • Track 2-9Molecular mechanisms of Viral Infection
  • Track 3-1Chancroid
  • Track 3-2Chlamydia
  • Track 3-3Gonorrhea
  • Track 3-4Lymphogranuloma Venereum
  • Track 3-5Mycoplasma Genitalium
  • Track 3-6Syphilis
  • Track 3-7Molecular Mechanism of Bacterial STI
  • Track 3-8Zinc Deficiencies and Bacterial Infection
  • Track 4-1Trichomoniasis
  • Track 4-2Toxoplasmosis
  • Track 4-3Babesiosis
  • Track 4-4Giardiasis
  • Track 4-5Drug Targets and Mechanisms of resistance
  • Track 5-1Genetic disorder
  • Track 5-2Poor growth
  • Track 5-3Premature birth
  • Track 5-4Pelvic Inflammatory Disease
  • Track 5-5Mental retardation
  • Track 5-6Low birth weighs
  • Track 6-1Hemorrhagic fever
  • Track 6-2HIV & Polio virus
  • Track 6-3Measles
  • Track 6-4Renal and Urologic Abnormalities
  • Track 6-5Cardiovascular Diseases
  • Track 6-6Malaria and Chickungunya
  • Track 6-7Rabies
  • Track 6-8Anthrax
  • Track 6-9Yellow fever
  • Track 6-10Encephalitis
  • Track 6-11Zika virus & West nile virus
  • Track 7-1Roles of Core Groups
  • Track 7-2Sexually transmitted infection (STI)-related enteric infections
  • Track 7-3Infection strategies through pathogen Human Protein- Protein Interactions
  • Track 7-4Antigenic variations a way of escape for pathogens
  • Track 8-1T helper cells response
  • Track 8-2Regulatory T cells response
  • Track 8-3Memory T cells response
  • Track 8-4B cells and Antibody Factory response
  • Track 8-5Mechanism of action of Antibody response
  • Track 9-1Designer Nucleases approach
  • Track 9-2Gene manipulations approach
  • Track 9-3Anti HIV gene approach
  • Track 10-1Hybridization techniques
  • Track 10-2Amplification techniques
  • Track 10-3Nucleic Acid Amplification Tests
  • Track 11-1Antibody Tests
  • Track 11-2HIV RNA
  • Track 11-3Whiff Test
  • Track 11-4Immune chromatographic Assays
  • Track 11-5Nucleic Acid Amplification Tests
  • Track 11-6CSF examination
  • Track 12-1Anti-HIV Drug Discovery
  • Track 12-2LASER ART (long acting slow effective release antiretroviral therapy)
  • Track 12-3Expedited Partner Therapies
  • Track 12-4Jarisch-Herxheimer reactions
  • Track 12-5Bacterial Azurin a novel anticancer agent
  • Track 13-1Good hygienic practices
  • Track 13-2Diagnosis of infectious diseases
  • Track 13-3HPV Vaccines
  • Track 13-4HPV Vaccines
  • Track 13-5Genital Herpes vaccines
  • Track 13-6Antiviral therapy
  • Track 13-7Tetracycline tablets
  • Track 13-8Ciprofloxacin
  • Track 13-9STD affects during pregnancy
  • Track 14-1Types of STD during pregnancy
  • Track 14-2Drugs for prevention of MTCT
  • Track 15-1STD-AIDS Testing Market by testing devices
  • Track 15-2STD-AIDS Testing Market by location
  • Track 15-3STD-AIDS Testing Market by geography
  • Track 15-4Private & public laboratory testing
  • Track 15-5Technological Advancements for STDs diagnostic market
  • Track 15-6Market Dynamics
  • Track 16-1Ebola Outbreak
  • Track 16-2Ebola Epidemiology and advances
  • Track 16-3Molecular genetics of Ebola Virus
  • Track 16-4Experimental Treatments for Ebola Viral Disease
  • Track 16-5Molecular mechanisms of Ebola Virus Pathogenesis
  • Track 17-1Routes of Transmission and Mechanism
  • Track 17-2Molecular genetic of Zoonotic Diseases
  • Track 17-3Molecular genetic of Zoonotic Diseases
  • Track 17-4Symptoms and Drug treatment
  • Track 17-5Detection of the pathogen
  • Track 17-6Infectious Diseases modeling
  • Track 17-7Advancements in bioinformatics for Diagnosis
  • Track 18-1Genotyping assisted infectious disease control
  • Track 18-2Genome profiling of the pathogens
  • Track 18-3Phylogenetic tree analyses
  • Track 19-1Genetic Jugglery for resistance
  • Track 19-2Intrinsic Resistance for survival
  • Track 19-3Resistome for the resistance
  • Track 19-4Modes and mechanisms of transmission
  • Track 20-1Advancements in Construction method of Databases
  • Track 20-2Levels of Databases
  • Track 20-3Database for Annotation, Visualization, and Integrated Discovery
  • Track 21-1HVP mode of cancer development
  • Track 21-2Bacterially driven carcinogenesis
  • Track 21-3Invasive fungal infection and cancer